Diffusely Abnormal White Matter in Multiple Sclerosis: Further Histologic Studies Provide Evidence for a Primary Lipid Abnormality With Neurodegeneration
暂无分享,去创建一个
Piotr Kozlowski | Alex L. MacKay | Guojun Zhao | Cornelia Laule | Esther Leung | G. R. Wayne Moore | Anthony L. Traboulsee | A. MacKay | C. Laule | A. Traboulsee | A. Mackay | E. Leung | G. Moore | P. Kozlowski | David K B Li | G. Moore | David K. B. Li | Vlady Pavlova | Guojun Zhao | Vlady Pavlova
[1] G J Barker,et al. Stereotactic co‐registration of magnetic resonance imaging and histopathology in post‐mortem multiple sclerosis brain , 2003, Neuropathology and applied neurobiology.
[2] Christopher M. Taylor,et al. The Transport, Assembly, and Function of Myelin Lipids , 2004 .
[3] P. Riekkinen,et al. Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects , 2004, Zeitschrift für Neurologie.
[4] C. Ford,et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis , 1996, Neurology.
[5] G J Barker,et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.
[6] C. Laule,et al. Dirty-appearing white matter in multiple sclerosis , 2008, Journal of Neurology.
[7] B. Gerstl,et al. Brain lipids in multiple sclerosis and other diseases. , 1961, Brain : a journal of neurology.
[8] A. Weil. A RAPID METHOD FOR STAINING MYELIN SHEATHS , 1928 .
[9] P. Moreau. Lipids , 2007 .
[10] A. S. Hall,et al. NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.
[11] J Versijpt,et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.
[12] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[13] P. Calabresi,et al. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis , 2008, Brain : a journal of neurology.
[14] R Stollberger,et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[15] Alan C. Evans,et al. Neuroimaging in multiple sclerosis. , 1995, Neurologic clinics.
[16] C. Alling,et al. Lipid alterations in apparently normal white matter in multiple sclerosis. , 1971, Brain research.
[17] W. Brück,et al. Interplay between mechanisms of damage and repair in multiple sclerosis , 2008, Journal of Neurology.
[18] Douglas L. Arnold,et al. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter , 2006, NeuroImage.
[19] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[20] H. Woelk,et al. Investigations of the lipid metabolism of the white matter in multiple sclerosis Changes in glycero-phosphatides and lipid-splitting enzymes , 1982, Neurochemical Research.
[21] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[22] P. Cunnea,et al. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. , 2009, Biochemical Society transactions.
[23] D. Chari,et al. Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.
[24] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[25] Nikos Evangelou,et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.
[26] Catrin S. Rutland. Histological and Histochemical Methods 4th Edition , 2008 .
[27] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.
[28] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[29] Y. Itoyama,et al. Immunocytochemical observations on the distribution of myelin‐associated glycoprotein and myelin basic protein in multiple sclerosis lesions , 1980, Annals of neurology.
[30] J. Cumings. Lipid chemistry of the brain in demyelinating diseases. , 1955, Brain : a journal of neurology.
[31] W. Mcdonald,et al. The pathological evolution of multiple sclerosis , 1992, Neuropathology and applied neurobiology.
[32] T. N. Salthouse,et al. Luxol fast blue ARN: a new solvent azo dye with improved staining qualities for myelin and phospholipids. , 1962, Stain technology.
[33] P. Adamson,et al. Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] D D Breimer,et al. The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.
[35] B. Trapp,et al. Structure of the Myelinated Axon , 2004 .
[36] N. Gourtsoyiannis,et al. T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio , 2004, European Radiology.
[37] C. W. Adams,et al. HISTOCHEMISTRY OF MYELIN. XIII DIGESTION OF BASIC PROTEIN OUTSIDE ACUTE PLAQUES OF MULTIPLE SCLEROSIS , 1971 .
[38] Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. , 2002, Brain pathology.
[39] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[40] F. Barkhof,et al. Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types , 2010, American Journal of Neuroradiology.
[41] P. Sørensen,et al. Demyelination versus remyelination in progressive multiple sclerosis. , 2010, Brain : a journal of neurology.
[42] J. Clausen,et al. MYELIN CONSTITUENTS OF HUMAN CENTRAL NERVOUS SYSTEM , 1970, Acta neurologica Scandinavica.
[43] Jimmy Lee,et al. Reproducibility of myelin water fraction analysis: a comparison of region of interest and voxel-based analysis methods. , 2009, Magnetic resonance imaging.
[44] L. Eng,et al. LIPIDS AND PROTEINS IN MULTIPLE SCLEROSIS WHITE MATTER 1 , 1970, Journal of neurochemistry.
[45] P. Scheltens,et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.
[46] R. Shi,et al. Acrolein induces myelin damage in mammalian spinal cord , 2011, Journal of neurochemistry.
[47] F Barkhof,et al. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.
[48] Kenneth J. Smith,et al. Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.
[49] J. Cossins,et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions , 1997, Acta Neuropathologica.
[50] Alex L. MacKay,et al. Quantitative interpretation of NMR relaxation data , 1989 .
[51] Piotr Kozlowski,et al. Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology , 2008, NeuroImage.
[52] A. J. Thompson,et al. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis , 2003, Journal of Neurology.
[53] J. Newcombe,et al. White Matter Proteins in Multiple Sclerosis , 1980, Journal of neurochemistry.
[54] Frederik Barkhof,et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. , 2009, Archives of neurology.
[55] C. Laule,et al. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis , 2010, Multiple sclerosis.
[56] S. Nelson,et al. Multislice Brain Myelin Water Fractions at 3T in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[57] K. Suzuki,et al. Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter. , 1973, Archives of neurology.
[58] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[59] A J Thompson,et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.
[60] A. Thompson,et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.
[61] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[62] I. V. Allen,et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.
[63] F. Barkhof,et al. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: Direct postmortem in situ magnetic resonance imaging correlated with in vitro high‐resolution magnetic resonance imaging and histopathology , 2002, Annals of neurology.
[64] C. Laule,et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.
[65] H. Klüver,et al. A method for the combined staining of cells and fibers in the nervous system. , 1953, Journal of neuropathology and experimental neurology.
[66] S Ropele,et al. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease , 2007, Multiple sclerosis.
[67] F. Barkhof,et al. Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis , 2005, Neurobiology of Disease.
[68] G. Comi,et al. MRI quantification of gray and white matter damage in patients with early–onset multiple sclerosis , 2006, Journal of Neurology.
[69] Frederik Barkhof,et al. Multislice T1 relaxation time measurements in the brain using IR‐EPI: Reproducibility, normal values, and histogram analysis in patients with multiple sclerosis , 2003, Journal of magnetic resonance imaging : JMRI.
[70] Piotr Kozlowski,et al. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology , 2011, Multiple sclerosis.
[71] R M Lycette,et al. The binding of luxol fast blue ARN by various biological lipids. , 1970, Stain technology.
[72] Christine Stadelmann,et al. Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis , 2010, Brain pathology.
[73] J. Newcombe,et al. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter , 2010, Neuroscience Letters.
[74] I. Allen,et al. Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). , 1981, Acta neuropathologica. Supplementum.
[75] Craig K. Jones,et al. Normal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2 , 2002, Magnetic resonance in medicine.
[76] P. Garland. Lipid Chemistry , 2020, Nature.
[77] J. Whitaker. The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis , 1978, Annals of neurology.
[78] J. Babb,et al. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. , 2003, AJNR. American journal of neuroradiology.
[79] H. Lassmann,et al. Chapter 1 – The story of multiple sclerosis , 2006 .
[80] P. Riekkinen,et al. Studies on the Pathogenesis of Multiple Sclerosis , 1971 .
[81] K. Misulis,et al. DEMYELINATING diseases. , 1952, Lancet.
[82] J A Frank,et al. MRI T2 lesion burden in multiple sclerosis , 2006, Neurology.
[83] R. Brady,et al. Quantitation of the Myelin‐Associated Glycoprotein in Human Nervous Tissue from Controls and Multiple Sclerosis Patients , 1986, Journal of neurochemistry.
[84] J. Geurts,et al. Gray matter imaging in multiple sclerosis: what have we learned? , 2011, BMC neurology.
[85] G Macchi,et al. An in vivo and post mortem MRI study in multiple sclerosis with pathological correlation. , 1992, Italian journal of neurological sciences.
[86] Massimo Filippi,et al. The role of advanced magnetic resonance imaging techniques in primary progressive MS , 2012, Journal of Neurology.
[87] H. Debuch,et al. 2′, 3′‐Cyclic Nucleotide 3′‐Phosphohydrolase and Lipids of Myelin from Multiple Sclerosis and Normal Brains , 1980, Journal of neurochemistry.
[88] L. Laitinen,et al. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. , 1973, European neurology.
[89] T. Inoue,et al. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study , 1987, Journal of the Neurological Sciences.
[90] M. Filippi,et al. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. , 2011, Radiology.
[91] Helga E. de Vries,et al. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions , 2003, Journal of Neuroimmunology.
[92] J. Bancroft,et al. Theory and Practice of Histological Techniques , 1990 .
[93] F. Barkhof,et al. Spinal cord magnetic resonance imaging in suspected multiple sclerosis , 2000, European Radiology.